REGN vs WOLF
Regeneron Pharmaceuticals Inc (REGN) versus Wolfspeed Inc (WOLF) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Wolfspeed Inc (WOLF) is a semiconductors company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WOLF revenue for 2025-06-29 was $757.6M. Net income was -$1.61B. Revenue was down 6.1% from 2024-06-30 to 2025-06-29. WOLF currently screens at market cap $183.6M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WOLF currently screens at market cap $183.6M.
Not investment advice. Open the REGN and WOLF stock pages for the full models.
Not investment advice.